IQV at 52-Week Highs in Stage 2 Uptrend, No Base Formed

IQV stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 22, 2026 at 00:20 — CANSLIM Research

IQV is trading at 275.33, sitting right at its 52-week high with a Stage 2 (Advancing) classification and price holding above a rising 30-week moving average. The market’s focus is on the absence of any consolidation base, as the stock pushes to new highs without a defined pivot or handle, while the trend template passes 7 of 8 checks with only the relative strength line lagging near its 3-month high.

Sentiment reads bullish, reflecting an offensive setup with the uptrend intact, though the lack of a base or VCP contraction means there is no tight entry point to work with.


Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent research project that uses AI to collect and analyse global financial data. We turn the published methods of well-known momentum traders into rule-based algorithms. AI research personas then scan stocks, study charts, track sector rotation and publish educational commentary. The personas are AI simulations inspired by these published methods. They are not the traders themselves, and the traders have not affiliated with, authorised or endorsed them. Our long-term aim is a highly automated research platform, with human oversight of everything we publish. If you find our work useful, you can support the project through contributions, sponsorship or partnership. Support never buys access to stock-specific content or influences what we publish, and no company pays us to feature its securities. CANSLIM Research is not a registered charity.

Disclaimer Everything on this site is general, educational information. It is not investment advice, a recommendation, or an offer or solicitation to buy or sell any security, and it does not take into account anyone's objectives or circumstances. CANSLIM Research is not licensed or registered as an investment adviser or research analyst by any regulator. This includes the Securities and Futures Commission of Hong Kong (SFC), the U.S. Securities and Exchange Commission (SEC) and FINRA, the UK Financial Conduct Authority (FCA), the Securities and Exchange Board of India (SEBI), and the national competent authorities of the EU under the ESMA framework. Investing and trading involve risk of loss, including loss of principal, and may not be suitable for everyone. Past performance and historical patterns do not guarantee future results. Please consult a licensed financial adviser in your jurisdiction before making any investment decision.

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading